Whitehawk Therapeutics, Inc. (WHWK) › Operating Cash FlowWhitehawk Therapeutics, Inc. (WHWK) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$19.2K2011: -$22.8K2012: -$24.5K2013: -$23.3K2014: -$16.0K2015: -$21.7K2016: -$24.5K2017: -$18.88M2018: -$5.81M2019: -$23.85M2020: -$12.70M2021: -$22.42M2022: -$49.64M2023: -$59.66M2024: -$59.55M2025: -$97.43M-$97.43M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$97.43M-63.6%2024-$59.55M+0.2%2023-$59.66M-20.2%2022-$49.64M-121.4%2021-$22.42M-76.5%2020-$12.70M+46.8%2019-$23.85M-310.7%2018-$5.81M+69.2%2017-$18.88M-76922.2%2016-$24.5K-12.8%2015-$21.7K-35.7%2014-$16.0K+31.3%2013-$23.3K+4.9%2012-$24.5K-7.7%2011-$22.8K-18.3%2010-$19.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share